Nothing would change as to the partnerships we currently have and they will produce revenue. The potential of having therapeutics would decrease but Dr. Moro is pretty far along in that area so the other employees of Pacific BioSciences could probably carry out the process. As far as someone to run the company, Wittenberg would be dead weight in that regard but Phil Gold would be able to hire a successor.
News 
Market Data 
Discover 
